Study of Antithymocyte Globulin for Treatment of New-onset T1DM (START)
收藏官方服务：
资源简介：
Antithymocyte globulin (e.g., Thymoglobulin) is an antibody preparation that is commonly used to treat and prevent organ transplant rejection. The START trial aims to determine whether antithymocyte globulin (ATG) treatment can halt the progression of newly diagnosed type 1 diabetes when given within 12 weeks of disease diagnosis.
提供机构：
ImmPort创建时间：
2020-04-16
